ISO 13485 Clause Map for Sterilization Packaging and Consumables: What a Canadian Importer Must Hold Against 21 CFR 820

CliniEco Class 4 self-sealing sterilization pouch, 200 per box

Since 2 February 2026 the United States quality regulation for medical devices no longer contains its own design, purchasing, process-validation or CAPA sections: 21 CFR 820 incorporates ISO 13485:2016 by reference and keeps only a small set of supplemental provisions. That makes a clause map useful again, because the same standard now answers both a manufacturer's question and an importer's question — but with different obligations attached. This map sets out what the current Part 820 actually contains, where each ISO 13485 clause hooks into it, and what a Canadian importer or distributor of sterilization consumables must hold in its own right rather than wait to receive.

Quick Summary: 21 CFR 820 was replaced in substance by the Quality Management System Regulation, effective 2 February 2026, which incorporates ISO 13485:2016 by reference at 820.7 and requires a documented quality management system under 820.10. The old 820.30 design controls, 820.50 purchasing controls and 820.75 process validation sections are now reserved, with their substance carried by ISO 13485 clauses. A Canadian importer's obligations do not come from Part 820 at all — they come from the establishment-licence and distribution-record provisions of the Medical Devices Regulations.

For a consumables buyer, the document trail starts with what is physically released: sterilization pouches such as our CliniEco self-sealing sterilization pouch, 2.5 x 4 inch, Class 4 dual indicator, 200 per boxClass 4 self-sealing dual-indicator pouches — 200 per box carry batch and indicator data that a clinic files, while the manufacturer's batch records carry the process data behind them.

CliniEco Class 4 self-sealing sterilization pouch, 200 per box, single pouch photographed
For a consumable, the clause map ends at a physical lot: label check, batch record and traceability all attach to the pouch in your hand.

What does 21 CFR 820 contain now?

The structure is worth reading from the regulation rather than from a consultant's summary, because the reserved sections are the point. Subpart A holds scope, definitions, incorporation by reference and the quality management system requirement; Subpart B holds only two live sections, on records and on labelling and packaging; Subparts C through O are reserved (21 CFR Part 820).

Section Status What it does
820.1 Scope Live Sets CGMP requirements in the QMSR; expressly includes contract sterilization, relabelling, repacking and specification development among manufacturer functions
820.3 Definitions Live Terms drawn from ISO 9000:2015 clause 3, incorporated by reference
820.5 Reserved —
820.7 Incorporation by reference Live Incorporates ISO 9000:2015 clause 3 and ISO 13485:2016, third edition, 1 March 2016
820.10 Requirements for a quality management system Live Requires a documented QMS complying with ISO 13485, plus named cross-references and design-control applicability
820.20 to 820.30 Reserved Former management, design-control, document-control and purchasing-control sections
820.35 Control of records Live Adds record content for complaints and servicing in addition to ISO 13485 clause 4.2.5
820.40 Reserved Former document-control section
820.45 Device labelling and packaging controls Live Adds labelling and packaging examination requirements in addition to ISO 13485 clause 7.5.1
Subparts C to O Reserved Former production, CAPA and records subparts

Two consequences matter for a supplier questionnaire. First, a supplier who answers "we comply with 21 CFR 820.75 process validation" is answering against a reserved section; the correct answer names ISO 13485 clause 7.5.6 and 7.5.7. Second, the rule did not remove FDA-specific obligations — it relocated them. Design and development controls now attach through 820.10(c), which requires ISO 13485 clause 7.3 for class II and class III devices and for the class I devices listed in the regulation, including devices automated with computer software. The final rule and its effective date are recorded in the Federal Register (89 FR 7496, 2 February 2024, effective 2 February 2026), and the operative text is the eCFR version cited above.

Where do the ISO 13485 clauses hook into the regulation?

The regulation does the mapping itself, in four places that a quality agreement should quote back rather than paraphrase.

  • 820.10(b) names the ISO clauses that require additional FDA-specific systems: clause 7.5.8 identification connects to unique device identification under 21 CFR Part 830; clause 7.5.9.1 traceability connects to Part 821 where applicable; clause 8.2.3 reporting to regulatory authorities connects to Part 803; and clauses 7.2.3, 8.2.3 and 8.3.3 advisory notices connect to Part 806 (820.10).
  • 820.35 keeps complaint records at a defined granularity — device name, date received, UDI or UPC, complainant details, nature of the complaint, correction or corrective action taken, and any reply — and adds servicing activity records (820.35).
  • 820.45 requires labelling and packaging to be examined for accuracy before release, naming UDI or UPC, expiry date, storage instructions, handling instructions and additional processing instructions (820.45).
  • 820.7 fixes the edition: ISO 13485:2016 third edition. That edition, not a later draft, is what the regulation points at (ISO 13485:2016 catalogue record).

For the clause-by-clause layer, the table below maps the clauses that matter for sterilization consumables and splits the output into the two columns buyers actually need.

ISO 13485 clause QMSR hook Manufacturer must provide Canadian importer must hold
4.2.4 / 4.2.5 Document and record control 820.35 Controlled procedures with retention periods, plus complaint and servicing records at the 820.35 granularity Current controlled copies of the documents you rely on, and the retention statement for the records you keep
7.3 Design and development 820.10(c) for class II, III and listed class I devices Design inputs and outputs, verification and validation, design transfer, design file A statement of whether the device is in scope of 820.10(c), and the design-change notification route
7.4 Purchasing ISO 13485 itself Supplier evaluation, purchasing information, verification of purchased product, supplier monitoring results Supplier approval status for your own sub-suppliers if you repack or relabel
7.5.1 Control of production 820.45 for labelling and packaging Work instructions, process parameters, labelling accuracy checks before release Evidence that the labelling on the lot you receive passed a documented check
7.5.5 Sterile medical devices ISO 13485 itself Records of sterilization process parameters for each sterilization batch, traceable to each production batch Batch-to-cycle linkage for the lots you distribute
7.5.6 Process validation ISO 13485 itself Validation and revalidation of processes where output cannot be verified by later monitoring The revalidation trigger list and the date of the last revalidation
7.5.7 Sterilization and sterile barrier systems ISO 13485 itself Validation of sterilization processes and sterile barrier systems, including revalidation on change The validated parameters, the load configuration and the packaging validation reference
7.5.8 / 7.5.9 Identification and traceability 820.10(b) to Parts 830 and 821 UDI assignment, traceability records, distribution records Lot-level traceability that matches what you record under section 52 of the Canadian regulations
8.2.2 Complaint handling 820.35 for record content Complaint intake, evaluation, investigation, and the justification for not investigating A complaint channel that reaches the manufacturer, and a log of what you forwarded
8.2.3 Regulatory reporting 820.10(b) to Parts 803 and 806 MDR and advisory notice decisions and timelines Your own Canadian reporting obligation, which runs on a different clock
8.3 Nonconforming product ISO 13485 itself Segregation, disposition, concession records The quarantine instruction you follow when the manufacturer reports a nonconformance
8.5.2 / 8.5.3 Corrective and preventive action ISO 13485 itself CAPA records tied to complaints, nonconformities and audit findings Notice of CAPAs that affect product you already hold

The sterilization row is the one buyers under-document. ISO 13485 clause 7.5.5 states that the organization "shall maintain records of the sterilization process parameters used for each sterilization batch" and that "sterilization records shall be traceable to each production batch of medical devices" (clause text as reproduced in a QMSR crosswalk). That is a two-way link: from a production lot you must be able to reach the cycle, and from a cycle you must be able to list every lot processed in it. A supplier who can show a cycle chart but cannot answer the reverse question has not met the clause. On the clinic side the same logic runs through spore checks such as the 24-hour self-contained biological indicators — 50-pack, where each result is filed against a cycle identifier rather than a date.

Nitrile examination gloves, 4 mil, blue, 1,000 gloves per case, photographed
Non-sterile consumables follow the same importer duties as sterile ones; only the manufacturing clauses that apply to them differ.

What must a Canadian importer hold in its own right?

Part 820 does not govern a Canadian importer that does not place the device on the US market. The Canadian obligations come from the Medical Devices Regulations, and they are documentary rather than certificational: no provision requires an ISO 13485 certificate as a condition of importing or selling in Canada. What the regulations require is an establishment licence, and the licence application is where the documentary evidence is tested.

Under section 44, no person may import or sell a medical device without an establishment licence, subject to exemptions for retailers, health care facilities and manufacturers in defined circumstances, and an importer must ensure that the person it imports from holds a licence (section 44). The application itself, at section 45, is a documentary test rather than a fee: it asks for the establishment's identity and representative, whether the activity is importation or distribution, the manufacturers and their addresses, the device classes, and — in the paragraphs that matter most here — attestations that documented procedures exist.

Obligation Legal hook What you hold as evidence today
Establishment licence before import or sale Section 44(1) The licence, with the activity and device classes on it
Documented procedures for distribution records, complaint handling and recalls Section 45(g) attestation Three controlled procedures, versioned and signed
Documented procedures for incident reports on imported class I devices Section 45(h) attestation Report procedure with the 10-day and 30-day clocks written into it
Documented procedures for reports and information provision on imported class II to IV devices Section 45(h.1) attestation Report procedure plus the information-provision route
Documented procedures for handling, storage, delivery, installation, corrective action and servicing Section 45(i) attestation The relevant subset for the products you actually distribute
Distribution record for each device Section 52, with section 53 Lot-level records sufficient for complete and rapid recall
Preliminary and final incident reports Sections 59 and 60 A log showing awareness date, report date and follow-up
Labelling: the word "Sterile" only where intended to be sold sterile, and bilingual information Sections 21 and 23 The approved label artwork and the bilingual review record

The reporting clock is the part most often mis-stated internally. A preliminary report is due within 10 days of becoming aware of an incident that led to death or serious deterioration, and within 30 days where it did not but could do so were it to recur (section 60). Both the manufacturer and the importer owe reports, not the manufacturer alone (section 59).

What changes on 1 December 2026?

A second phase of the establishment-licence amendments changes the shape of that table, and the change is one of form rather than of substance: attestations give way to documented procedures and supplier information.

The amending instrument was registered on 4 June 2026 and comes into force on the 180th day after registration, which is 1 December 2026 (Canada Gazette Part II, SOR/2026-110). Three changes matter to an importer of sterilization consumables:

  • Supplier information replaces the specialities field. The application gains the name and address of any person other than the manufacturer who sells the device to the establishment for importation or distribution, and the classes of devices for each such person.
  • The attestation paragraphs are repealed. The section 45(g) to (i) attestations are replaced by an obligation to establish, implement and maintain documented procedures — for distribution records, for investigation and recall, for handling, storage, delivery, installation, servicing and corrective action, and for reporting and information provision.
  • The building list is re-pointed. The address requirement now refers to the buildings where the procedures under those substantive provisions are in place, rather than to the buildings named in the repealed attestations.

The practical preparation is unglamorous: convert three attestations into three controlled procedures with owners, revision history and a training record, and build the supplier list in the format the licence form expects. Importers who already hold procedures for complaints and recalls will find the gap is in the servicing, handling and information-provision procedures, which historically existed as practice rather than as documents.

What should the supplier quality agreement say?

Whether you buy from a Canadian manufacturer or from an overseas one, the agreement is where the clause map becomes enforceable. Five clauses carry most of the weight:

  1. A named edition statement — ISO 13485:2016, and a statement of which standard edition governs sterilization validation, updated when the underlying standard is revised.
  2. A batch-record deliverable, not a certificate: the sterilization batch parameters tied to the lots shipped to you, per clause 7.5.5.
  3. A change-notification clause with a defined notice period for changes to process, site, sterilization modality, packaging or sub-supplier, and a revalidation requirement attached to each.
  4. A complaint and CAPA route with an acknowledgement period and a named recipient, satisfying your section 45(g) and 45(h) procedure rather than sitting outside it.
  5. A recall cooperation clause that names the data fields you need to satisfy section 53, so the distribution record you keep is complete before you ever need it.

Two related reads give the rest of the frame: what ISO 13485 certification means for Canadian medical supply buyers covers what a certificate does and does not evidence, and the supplier verification questions a clinic should ask in writing is the clinic-level version of the same list. Buyers comparing the two jurisdictions will also want the walkthrough of the US 21 CFR 880 and 820 path for a Canadian maker, which predates the QMSR rewrite and therefore shows exactly which section numbers changed.

For institutional purchasing, the wholesale and institutional supply account route handles multi-site orders and document requests together, the sterilization compliance hub collects the compliance side, and the free compliance log centre provides the clinic-level log sheets that sit under your own procedure. Where a distributor has to answer a provincial inspector rather than a supplier auditor, compliance consultation is the escalation route. Reselling? become a distributor.

Related reading

Frequently Asked Questions

Is 21 CFR 820 still the right reference for a US buyer in 2026?

The part is still numbered 820, but its content changed on 2 February 2026. It now incorporates ISO 13485:2016 by reference and retains supplemental sections on records and on labelling and packaging. Quoting the old design-control or process-validation section numbers points at reserved text.

Does a Canadian importer need ISO 13485 certification?

No. The Medical Devices Regulations require an establishment licence and documented procedures, not a certificate. ISO 13485 is a route to demonstrating control over the processes behind the product, and it is the standard the US regulation now points at, but it is not a Canadian licensing condition in its own right.

Which ISO 13485 edition applies?

The 2016 edition, third edition dated 1 March 2016. That is the edition incorporated at 820.7 and the edition against which suppliers are audited. A supplier citing a superseded 2003 edition is describing a certificate that no longer maps to the current US requirement.

Who keeps the sterilization batch records — the manufacturer or the contract sterilizer?

The requirement sits with the manufacturer, and the records are usually created at the sterilizer. Clause 7.5.5 places the obligation to maintain the records and the traceability to production batches on the organization placing the device on the market, which is why the quality agreement has to make the sterilizer's records deliverable rather than merely available on request.

What happens to the section 45 attestations after 1 December 2026?

They are repealed and replaced by an obligation to establish, implement and maintain documented procedures for distribution records, investigation and recall, handling and servicing, and reporting. The change affects form and evidence rather than the underlying duty, and it applies to importers and distributors rather than to manufacturers.

Do distribution records belong to the importer or the manufacturer?

Both. Section 52 places the duty to maintain a distribution record on the manufacturer, the importer and the distributor separately, and section 53 sets the test: enough information to permit complete and rapid recall of the device. Each party is expected to be able to run that trace without depending on another party's system.

How does this affect consumables such as pouches, indicators and gloves?

The same clauses apply, with the emphasis different. Sterile barrier systems and indicators are covered by the sterilization and validation clauses, gloves and other non-sterile consumables by production control, labelling and traceability. The importer-side obligations are identical because they attach to importing a device, not to the device class.

CliniEco Medical distributes medical consumables under Health Canada MDEL #35334. This map describes the regulatory framework for buyers and is not a substitute for the licence conditions on your own establishment licence.

Already working with clinics? Become a regional representative.